HDV Antigen Test at Biotech Lahore Lab

HDV Antigen at Biotech Lahore Lab

The Hepatitis D Virus (HDV) Antigen test is a highly specialized molecular and serological laboratory investigation designed to detect the presence of the Hepatitis Delta Virus antigen in a patient’s blood. Biotech Lahore Lab, located in Lahore, Pakistan, offers this critical diagnostic service to assist in the identification and management of HDV infections. Hepatitis D is a unique and severe form of viral hepatitis caused by HDV, a subviral satellite that can only replicate in the presence of the Hepatitis B Virus (HBV). Therefore, an HDV infection occurs either as a co-infection alongside an acute HBV infection or as a superinfection in individuals who are already chronic carriers of Hepatitis B. Understanding the presence of the HDV antigen is clinically vital because HDV-HBV co-infections and superinfections significantly accelerate the progression of chronic liver diseases, leading to a higher incidence of liver cirrhosis, hepatic decompensation, and hepatocellular carcinoma (liver cancer) compared to HBV infection alone.

At Biotech Lahore Lab, the HDV Antigen test is performed using advanced immunoassay technologies, such as Enzyme-Linked Immunosorbent Assay (ELISA) or chemiluminescent microparticle immunoassay (CMIA), which offer high sensitivity and specificity. The test detects the structural antigen of the delta virus (HDAg) in the serum or plasma of the patient. This laboratory evaluation plays a pivotal role in clinical decision-making, enabling hepatologists, gastroenterologists, and infectious disease specialists to formulate targeted therapeutic strategies, monitor disease progression, and assess the patient’s response to antiviral therapies. By identifying the HDV antigen early, healthcare providers can implement aggressive monitoring protocols and specialized treatment regimens, such as pegylated interferon-alpha or novel entry inhibitors, to mitigate the risk of end-stage liver disease.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the accuracy of the HDV Antigen test at Biotech Lahore Lab, patients should adhere to the following preparation guidelines:

• No Strict Fasting Required: Generally, fasting is not mandatory for the HDV Antigen test. However, if other concurrent blood tests (such as a fasting lipid profile or blood glucose test) are ordered alongside it, you may need to fast for 8 to 12 hours.
• Medication Disclosure: Inform your physician and the laboratory staff about all medications, vitamins, herbal supplements, and over-the-counter drugs you are currently taking, as certain immunomodulatory therapies could theoretically influence immune markers.
• Hydration: Drink plenty of water before the procedure. Being well-hydrated makes it easier for the phlebotomist to locate your veins, ensuring a quick and comfortable blood draw.
• Avoid Strenuous Exercise: Refrain from intense physical activity immediately before the test to maintain baseline physiological parameters.
• Carry Medical Documents: Bring your physician’s prescription and any previous hepatitis panel report or liver function test (LFT) results to assist the clinical team in contextualizing your case.

During the Procedure

The HDV Antigen test is a standard venipuncture procedure performed by trained phlebotomists at Biotech Lahore Lab. The process is designed to be safe, sterile, and highly efficient:

• Patient Positioning: You will be asked to sit comfortably in a blood collection chair. You should extend your arm on the armrest, exposing the inner elbow area (antecubital fossa).
• Sanitization: The phlebotomist will locate a suitable vein, typically the median cubital vein, and cleanse the overlying skin thoroughly with an antiseptic swab (usually 70% isopropyl alcohol) to prevent contamination.
• Tourniquet Application: A sterile elastic band (tourniquet) is tied around your upper arm to restrict blood flow temporarily, causing the veins to swell and become more visible and accessible.
• Sample Collection: A sterile, single-use needle attached to a vacuum collection tube (typically a gold-top serum separator tube or red-top tube) is gently inserted into the vein. You may feel a brief, mild pinch or prick.
• Tourniquet Release: Once the required volume of blood is collected into the tube, the tourniquet is released to restore normal blood circulation.
• Needle Removal and Pressure: The needle is carefully withdrawn, and a sterile cotton ball or gauze pad is immediately pressed onto the puncture site to control bleeding. A small adhesive bandage is then applied.
• Duration and Safety: The entire blood collection process takes less than 5 minutes. All materials used are strictly sterile and disposable, eliminating any risk of cross-contamination or infection.

When is an HDV Antigen Test Performed?

Chronic Hepatitis B Infection

Physicians routinely request an HDV Antigen test for patients diagnosed with chronic Hepatitis B who exhibit unexplained clinical deterioration. Because HDV requires the outer envelope of HBV to infect cells, any individual with chronic HBV is at risk of an HDV superinfection. This test helps clinicians determine if the sudden worsening of liver function is due to the acquisition of the delta virus, which demands a distinct therapeutic approach compared to standard HBV monotherapy.

Acute Hepatitis with Severe Symptoms

When a patient presents with signs of acute, severe viral hepatitis—such as intense jaundice, dark urine, extreme fatigue, and markedly elevated liver enzymes (ALT and AST)—and tests positive for HBV, the medical team will order an HDV Antigen test. This helps differentiate between a simple acute HBV infection and a simultaneous HBV/HDV co-infection. Co-infections can occasionally lead to fulminant hepatitis, a life-threatening condition characterized by rapid liver failure.

Unexplained Liver Cirrhosis Progression

In patients with known liver disease whose condition progresses rapidly toward cirrhosis or liver failure despite seemingly well-controlled HBV replication (low HBV DNA levels), an HDV Antigen test is strongly indicated. HDV is known to suppress HBV replication while independently driving severe liver inflammation and fibrogenesis. Identifying HDV explains the rapid clinical decline and guides the initiation of specific antiviral agents.

Screening High-Risk Populations

Healthcare providers recommend HDV screening for individuals in high-risk categories who are already positive for Hepatitis B Surface Antigen (HBsAg). This includes intravenous drug users, individuals undergoing frequent blood transfusions, patients on hemodialysis, and those living in geographic regions with high HDV endemicity. Early detection through screening prevents transmission and allows for proactive liver preservation strategies.

Monitoring Antiviral Therapy Response

For patients undergoing treatment for confirmed Hepatitis Delta, periodic HDV Antigen testing, often combined with HDV RNA quantitative PCR, is performed. This assists hepatologists in evaluating whether the antiviral therapy is successfully suppressing viral replication, reducing viral load, and clearing the antigen from the bloodstream, which signifies a favorable clinical response.

What Does an HDV Antigen Test Detect?

The HDV Antigen test specifically detects the presence of the Hepatitis Delta Virus antigen (HDAg) in the blood. A positive result indicates an active HDV infection, which could be either an acute co-infection or a chronic superinfection. A negative result suggests the absence of detectable HDV antigen at the time of testing, although further testing for HDV antibodies (Anti-HDV Total or IgM) or HDV RNA may be warranted if clinical suspicion remains high. Specifically, the test helps identify:

• Active replication of the Hepatitis Delta Virus.
• Acute HDV and HBV co-infection when evaluated alongside IgM anti-HBc.
• Chronic HDV superinfection in established HBsAg carriers.
• The underlying cause of rapid, severe liver inflammation (hepatitis flare).
• Potential risk of rapid progression to liver cirrhosis and portal hypertension.
• The necessity for advanced molecular testing, such as quantitative HDV RNA PCR.
• The eligibility of the patient for specialized liver-directed therapeutic protocols.

Turnaround Time and Report Access at Biotech Lahore Lab

Biotech Lahore Lab is committed to providing accurate and timely diagnostic reports. The turnaround time (TAT) for the HDV Antigen test is typically within 24 to 48 hours, depending on the specific testing schedule and methodology. Once the clinical pathologists verify the results, patients receive an automated SMS notification. Reports can be accessed online through the official Biotech Lahore Lab web portal or mobile application, allowing patients and their consulting physicians to review the findings promptly from the comfort of their homes.

HDV Antigen Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Hepatitis D Antigen (HDAg)	Negative / Non-reactive	Positive / Reactive (indicates active HDV infection)
HBsAg Co-status	Negative	Positive (essential for HDV survival and replication)
Liver Enzymes (ALT/AST)	Within normal reference range	Markedly elevated (indicates active hepatic inflammation)
Total Bilirubin	Normal (0.2 – 1.2 mg/dL)	Elevated (indicates jaundice and impaired liver clearance)
Prothrombin Time (PT/INR)	Normal range (INR ~1.0)	Prolonged INR (indicates impaired liver synthetic function)
Serum Albumin	Normal (3.5 – 5.0 g/dL)	Decreased (suggests chronic liver damage or cirrhosis)
HDV RNA (if reflexed)	Not detected	Detected (confirms active viral replication and quantifies viral load)

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Biotech Lahore Lab for HDV Antigen?

• Experienced Healthcare Professionals: Our laboratory is staffed by highly qualified pathologists and technologists specializing in infectious disease diagnostics.
• Patient-Focused Care: We prioritize patient comfort, safety, and confidentiality throughout the sample collection and reporting process.
• Quality Diagnostic Services: Biotech Lahore Lab adheres to stringent internal and external quality control protocols to ensure clinical accuracy.
• Professional Reporting: Reports are structured clearly, providing comprehensive reference ranges to assist physicians in rapid diagnosis.
• Modern Diagnostic Approach: We utilize advanced immunoassay platforms that deliver high analytical sensitivity for viral antigen detection.
• Comfortable Environment: Our collection centers in Lahore are designed to provide a clean, hygienic, and stress-free experience for patients.
• Convenient Location: Easily accessible diagnostic facilities across Lahore make it convenient for patients to undergo testing.
• Commitment to Accurate Diagnosis: We understand the critical nature of hepatitis diagnostics and are dedicated to delivering reliable results that impact patient outcomes positively.